North America Radiotherapy Market Size and Growth 2031

North America Radiotherapy Market Size and Forecast (2021-2031), Regional and Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Products and Software), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, and Specialty Clinics), and Geography

  • Report Code : TIPRE00025051
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 150
Buy Now

North America Radiotherapy Market Growth, Share by 2031

Buy Now

The North America radiotherapy market size is projected to reach US$ 8.46 billion by 2031 from US$ 3.85 billion in 2023. The market is expected to register a CAGR of 10.3% during 2023–2031. The rising prevalence of cancer globally is likely to remain a trend in the market.

North America Radiotherapy Market Analysis

Radiation therapy or radiotherapy is a type of cancer treatment. Intense energy beams are used in this treatment to eradicate cancer cells while shielding surrounding healthy tissues from radiation exposure. X-rays are often used in radiation therapy. However, many other forms of radiation therapy, such as proton radiation, are also gaining traction.

Players in the market should expect to see a broad range of growth opportunities due to the improving reimbursement scenario and growing government and private investments to meet the growing demand for cancer treatment. For example, 3.05 million Americans received radiation therapy in 2016, and that number is predicted to rise by ~37% to 4.17 million by 2040.

North America Radiotherapy Market Overview

The increasing adoption of advanced medical devices, technological advancements, and the rising prevalence of cancer are a few factors projected to boost the market growth in the coming years. Growing digitalization of medical devices, increasing adoption of advanced medical device technologies, growing emphasis on improving treatment outcomes, and rising prevalence of cancer are the factors likely drive the market growth. According to a study published by the American Cancer Society in 2024, approximately 13,820 women in the US were diagnosed with cervical cancer.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

North America Radiotherapy Market: Strategic Insights

north-america-radiotherapy-market
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

North America Radiotherapy Market Drivers and Opportunities

Increasing Number of Conferences and Symposiums to Boost Awareness About Radiation Therapy

In the last few years, there has been an increase in investments in research activities focused on early detection of cancer, as well as the development of new technologies for cancer treatment and management. The education & research centers, healthcare authorities, and market players actively participate in numerous conferences and symposiums to share knowledge and showcase new technologies. In addition, such programs are prominently contributing to the spread of awareness about radiation therapy. The Ivy Brain Tumor Center at Barrow Neurological Institute held a radiation therapy symposium in March 2024 to offer attendees a chance to extend their knowledge and proficiency in the most recent procedures and therapies associated with radiation oncology and other related fields. Further, the American Society of Radiologic Technologists will announce its plan to propose Radiation Therapy Conference 2024 in September 2024. Leading radiation oncology professionals across the globe, including radiation therapists and medical dosimetrists, will attend the ASRT Radiation Therapy Conference to discuss innovation and the future of the field. The conference will allow the therapists to share their ideas and new aspects of radiation therapy. In addition, in July 2022, the University of Maryland School of Medicine conducted a symposium on practical AI in radiation oncology. Such conferences and meetings boost innovation and new product developments across the globe. Thus, the increasing number of conferences and symposiums to boost awareness about radiation therapy drives the North America radiotherapy market

Cancer Screening Programs and Implementation of Standard Guidelines

The implementation of preventive healthcare and disease diagnosis programs is growing across North America. For instance, all provinces in Canada have breast cancer screening programs for women aged 50–74 years. The Provincial Health Services Authority of British Columbia has a breast cancer screening program that offers simple, inexpensive tests to a large population base; the program mainly aims toward the early diagnosis of breast cancer. Moreover, in November 2020, the WHO announced the initiation of a strategic program to accelerate the elimination of cervical cancer. The organization announced three key steps to achieve the objective: vaccination, screening, and treatment.

Further, the CDC is one of 19 national organizations that are members of the Comprehensive Cancer Control National Partnership (CCCNP). Its main goal is to support comprehensive cancer control coalitions in states, territories, tribes, and U.S. Pacific Island jurisdictions. Such programs will likely boost cancer detection, supporting a favorable environment for adopting radiotherapy across the region.

Governments and healthcare organizations are focusing on implementing strategic guidelines and policies. For instance, in March 2021, the International Atomic Energy Agency (IAEA) and the WHO collaborated to issue new guidelines for procuring radiotherapy to improve access to radiotherapy worldwide. These new technical guidelines focus on selecting radiotherapy equipment, its utilization, and quality maintenance by healthcare facilities. The organizations issued these guidelines to increase the adoption and awareness of radiotherapy in low and middle-income countries.

Thus, cancer screening programs and the implementation of standard guidelines are projected to serve as lucrative opportunities for the growth of the North America radiotherapy market during the forecast period.

North America Radiotherapy Market Report Segmentation Analysis

Key segments that contributed to the derivation of the North America radiotherapy market analysis are type, application, and end user.

  • Based on type, the North America radiotherapy market is divided into products and software. The products segment held a larger market share in 2023.
  • Based on application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. The breast cancer segment held the largest share in 2023.
  • In terms of end user, the market is segmented into hospitals, radiation therapy centers, and specialty clinics. The hospitals segment dominated the market in 2023.

North America Radiotherapy Market Share Analysis by Geography

The geographic scope of the North America radiotherapy market report is mainly divided into three countries: the US, Canada, and Mexico. Key factors driving the market include rising cancer prevalence and an increasing number of conferences and symposiums to boost awareness about radiation therapy.

North America Radiotherapy Market Report Scope

North America Radiotherapy Market News and Recent Developments

The North America radiotherapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the North America radiotherapy market are listed below:

  • Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating for its Elekta Unity MR-Linac had received U.S. FDA 510(k) clearance. True Tracking represents a milestone in the history of radiotherapy. For the first time in the U.S., Elekta Unity can continuously calculate the movement of the tumor anywhere in the body and account for it automatically. This functionality will allow clinicians to utilize the enhanced adaptive radiation therapy workflow to deal with moving organs and treat patients more accurately. (Source: Elekta, Press Release, February 2023)
  • The International Atomic Energy Agency (IAEA) joined forces with Siemens Healthineers to strengthen cancer diagnosis and treatment capacity in low- and middle-income countries, harnessing each other’s technical expertise in new ways to combat the rising global burden of this disease that kills millions of people every year. (Source: Siemens Healthineers, Newsletter, September 2023)

North America Radiotherapy Market Report Coverage and Deliverables

The “North America Radiotherapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

  • North America Radiotherapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • North America Radiotherapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • North America Radiotherapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the North America radiotherapy market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which end user segment is dominating the North America radiotherapy market?

The North America radiotherapy market by end user, is categorized into is categorized into hospitals, radiation therapy centers, and specialty clinics. The hospitals segment held the largest share of the market in 2023.

Which application form segment is dominating the North America radiotherapy market?

The North America radiotherapy market by application form is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. The breast cancer segment held the largest North America radiotherapy market share in 2023.

Which type segment is dominating the North America radiotherapy market?

The North America radiotherapy market, based on type, is segmented into products and software. The products segment held a larger share of the market in 2023.

Which country is dominated the North America radiotherapy market?

US holds the largest market share in North America radiotherapy market. There are several initiatives by the government and healthcare authorities to encourage the adoption of radiotherapy. Such strategies are likely to have a constructive impact on the US radiotherapy market. For instance, in June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guideline focuses on precisely implementing steps and processes to conduct radiation therapy. All these factors are expected to fuel the US radiotherapy market by 2031

What are the driving factors for the North America radiotherapy market across the globe?

The factors that are driving growth of the market are the rising prevalence of cancer and increasing number of conferences and symposiums to boost awareness about radiation therapy.

Who are the major players in the North America radiotherapy market?

The North America radiotherapy market majorly consists of the players such as Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries Ltd, Elekta AB, Hitachi Ltd, Koninklijke Philips NV, Brainlab AG, and PROTOM INTERNATIONAL.

What is radiotherapy?

One kind of cancer treatment is radiation therapy, sometimes known as radiotherapy. Intense energy beams are used in this treatment to eradicate cancer cells. X-rays are most frequently used in radiation therapy. However, there are other forms of radiation therapy, such as proton radiation.

1. Introduction

1.1 Scope of the Study

1.2 Market Definition, Assumptions and Limitations

1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness Analysis

3. Research Methodology

4. Radiotherapy Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Radiotherapy Market - Key Market Dynamics

5.1 Key Market Drivers

5.2 Key Market Restraints

5.3 Key Market Opportunities

5.4 Future Trends

5.5 Impact Analysis of Drivers and Restraints

6. Radiotherapy Market - North America Market Analysis

6.1 Radiotherapy - North America Market Overview

6.2 Radiotherapy - North America Market and Forecast to 2031

7. Radiotherapy Market – Revenue Analysis (USD Million) – By Type, 2021-2031

7.1 Overview

7.2 Products

7.2.1 External-Beam Radiation Therapy

7.2.2 Internal Radiation Therapy

7.2.3 Systemic Radiotherapy/Radiopharmaceuticals

7.3 Software

8. Radiotherapy Market – Revenue Analysis (USD Million) – By Application, 2021-2031

8.1 Overview

8.2 Breast Cancer

8.3 Lung Cancer

8.4 Prostate Cancer

8.5 Colorectal Cancer

8.6 Lymphoma

8.7 Liver Cancer

8.8 Thyroid Cancer

8.9 Brain Cancer

8.10 Cervical Cancer

8.11 Spine Cancer

8.12 Others

9. Radiotherapy Market – Revenue Analysis (USD Million) – By End User, 2021-2031

9.1 Overview

9.2 Hospitals

9.3 Radiation Therapy Centers

9.4 Specialty Clinics

10. Radiotherapy Market - Revenue Analysis (USD Million), 2021-2031 – Country Analysis

10.1 North America

10.1.1 North America Radiotherapy Market Overview

10.1.2 North America Radiotherapy Market Revenue and Forecasts to 2031

10.1.3 North America Radiotherapy Market Revenue and Forecasts and Analysis - By Type

10.1.4 North America Radiotherapy Market Revenue and Forecasts and Analysis - By Application

10.1.5 North America Radiotherapy Market Revenue and Forecasts and Analysis - By End User

10.1.6 North America Radiotherapy Market Revenue and Forecasts and Analysis - By Countries

10.1.6.1 United States Radiotherapy Market

10.1.6.1.1 United States Radiotherapy Market, by Type

10.1.6.1.2 United States Radiotherapy Market, by Application

10.1.6.1.3 United States Radiotherapy Market, by End User

10.1.6.2 Canada Radiotherapy Market

10.1.6.2.1 Canada Radiotherapy Market, by Type

10.1.6.2.2 Canada Radiotherapy Market, by Application

10.1.6.2.3 Canada Radiotherapy Market, by End User

10.1.6.3 Mexico Radiotherapy Market

10.1.6.3.1 Mexico Radiotherapy Market, by Type

10.1.6.3.2 Mexico Radiotherapy Market, by Application

10.1.6.3.3 Mexico Radiotherapy Market, by End User

11. Industry Landscape

11.1 Mergers and Acquisitions

11.2 Agreements, Collaborations, Joint Ventures

11.3 New Product Launches

11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players

12.2 Company Positioning and Concentration

13. Radiotherapy Market - Key Company Profiles

13.1 Siemens Healthineers AG

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

13.2 Accuray Incorporated

13.3 Sumitomo Heavy Industries Ltd

13.4 Elekta AB

13.5 Hitachi Ltd

13.6 Koninklijke Philips NV

13.7 Brainlab AG

13.8 PROTOM INTERNATIONAL

14. Appendix

14.1 Glossary

14.2 About The Insight Partners

14.3 Market Intelligence Cloud

The List of Companies - North America Radiotherapy Market

  1. Siemens Healthineers AG
  2. Accuray Incorporated
  3. Sumitomo Heavy Industries Ltd
  4. Elekta AB
  5. Hitachi Ltd
  6. Koninklijke Philips NV
  7. Brainlab AG
  8. PROTOM INTERNATIONAL

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..